The pharmacologist

Abstract

One in 10 adults has subjective tinnitus, and for 1 in 100 adults, tinnitus severely affects their quality of life. Despite the significant unmet clinical need for a safe and effective drug targeting tinnitus relief, there is currently not a single FDA-approved drug on the market. Since in some individuals tinnitus causes irritability, agitation, stress, depression, insomnia, and interferes with normal life, even a drug that produces a small but significant effect would have a huge therapeutic impact. A glimpse of hope is appearing in the near future, as some pharmaceutical industries now have compounds targeting tinnitus in their pipeline. If these compounds finally reach the market they will set a new era that will revolutionize the treatment of tinnitus.